Business Coach
9562
Artra Group
6029
Daiwa Cycle
5888
Liberta
4935
D. Western Therapeutics Institute
4576
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 24.83%280.63B | 6.07%1.05T | 12.67%278.18B | 1.68%270.03B | 6.05%277.19B | 3.96%224.81B | 11.34%990.09B | -5.39%246.9B | 13.17%265.57B | 21.23%261.38B |
Cost of revenue | 25.87%170.5B | 9.30%679.25B | 16.17%190.03B | 4.90%184.47B | 4.22%169.3B | 13.30%135.45B | 16.59%621.43B | 6.67%163.58B | 20.01%175.85B | 25.11%162.45B |
Gross profit | 23.25%110.13B | 0.62%370.96B | 5.79%88.15B | -4.63%85.56B | 9.06%107.9B | -7.58%89.36B | 3.48%368.66B | -22.56%83.32B | 1.79%89.72B | 15.37%98.93B |
Operating expense | 7.72%66.11B | 11.14%280.28B | 3.68%75.75B | 11.73%72.76B | 14.07%70.41B | 17.36%61.37B | 9.28%252.18B | -1.62%73.05B | 12.80%65.12B | 20.95%61.72B |
Operating profit | 57.29%44.02B | -22.14%90.68B | 20.74%12.4B | -47.95%12.8B | 0.74%37.49B | -36.95%27.99B | -7.19%116.47B | -69.20%10.27B | -19.10%24.6B | 7.16%37.21B |
Net non-operating interest income (expenses) | -95M | 181.21%2.38B | 137.29%2.6B | -1,444.44%-1.39B | 628.75%846M | 835.04%1.09B | -1.12%-90M | |||
Non-operating interest income | ---- | 128.27%2.69B | ---- | ---- | ---- | ---- | 442.86%1.18B | ---- | ---- | ---- |
Non-operating interest expense | --95M | -6.63%310M | 10.71%93M | ---- | ---- | ---- | -11.94%332M | -16.00%84M | 1.12%90M | ---- |
Net investment income | -40.07%2.08B | 24.37%8.05B | 146.51%3.29B | 135.99%701M | -51.21%586M | -40.96%3.47B | -4.22%6.47B | -76.50%1.33B | -396.95%-1.95B | 1,522.97%1.2B |
Gain(Loss) on financial instruments designated as cash flow hedges | 0 | -184M | 215M | 50.08%-297M | 0 | |||||
Gain(Loss) on derecognition of available-for-sale financial assets | 41.64%-157M | 6,482.21%44.48B | 92.23%-22M | -269M | -697M | -283M | ||||
Income from associates and other participating interests | 1.34B | -8.70%2.12B | 275.89%2.32B | |||||||
Special income (charges) | 291.57%159M | -84.89%-2.29B | -22.81%-1.21B | -231.88%-1.45B | 72.59%447M | -5.06%-83M | 54.57%-1.24B | 60.86%-982M | 53.67%-436M | 161.23%259M |
Less:Other special charges | -362.65%-218M | 4,830.77%615M | 735.29%142M | 502.67%904M | -98.46%-514M | 5.06%83M | 95.17%-13M | -90.61%17M | -70.99%150M | -171.35%-259M |
Less:Write off | --59M | 33.81%1.67B | 10.26%1.06B | --543M | ---- | ---- | -58.22%1.25B | -58.55%965M | ---- | ---- |
Other non-operating income (expenses) | 10.35%1.73B | -31.35%1.4B | -41.09%-5.41B | 125.66%4.6B | -71.43%640M | -1.63%1.57B | 78.46%2.04B | -597.81%-3.83B | 572.85%2.04B | 201.89%2.24B |
Income before tax | 51.54%49.07B | 16.18%146.64B | 510.80%58.09B | -40.50%14.54B | 1.35%41.62B | -36.75%32.38B | -3.57%126.22B | -73.24%9.51B | -19.87%24.44B | 17.55%41.07B |
Income tax | 41.61%15B | 25.80%45.13B | 354.40%17.13B | -4.09%6.17B | -2.30%11.23B | -25.26%10.59B | -6.33%35.87B | -19.05%3.77B | -22.70%6.43B | -29.63%11.5B |
Net income | 56.37%34.08B | 12.36%101.52B | 613.52%40.96B | -53.51%8.37B | 2.77%30.39B | -41.14%21.79B | -2.42%90.35B | -81.41%5.74B | -18.81%18.01B | 59.00%29.57B |
Net income continuous operations | 56.37%34.08B | 12.36%101.52B | 613.50%40.96B | -53.51%8.37B | 2.77%30.39B | -41.15%21.79B | -2.42%90.35B | -81.41%5.74B | -18.82%18.01B | 59.00%29.57B |
Noncontrolling interests | 500.00%24M | 21M | 16.35%-133M | 15.57%141M | -71.88%9M | -20.00%4M | 0 | 3.64%-159M | 1,642.86%122M | 366.67%32M |
Net income attributable to the company | 56.29%34.05B | 12.34%101.49B | 596.41%41.1B | -53.98%8.23B | 2.85%30.38B | -41.15%21.79B | -2.60%90.35B | -80.99%5.9B | -19.34%17.89B | 58.72%29.54B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 56.29%34.05B | 12.34%101.49B | 596.41%41.1B | -53.98%8.23B | 2.85%30.38B | -41.15%21.79B | -2.60%90.35B | -80.99%5.9B | -19.34%17.89B | 58.72%29.54B |
Gross dividend payment | ||||||||||
Basic earnings per share | 57.68%52.05 | 12.40%153.85 | 598.32%62.36 | -54.02%12.46 | 2.82%46.02 | -41.16%33.01 | -2.71%136.88 | -81.03%8.93 | -19.45%27.1 | 58.53%44.7593 |
Diluted earnings per share | 57.68%52.05 | 12.40%153.85 | 598.32%62.36 | -54.02%12.46 | 2.82%46.02 | -41.16%33.01 | -2.71%136.88 | -81.02%8.93 | -19.45%27.1 | 58.53%44.7593 |
Dividend per share | 0 | 11.11%20 | 11.11%10 | 0 | 11.11%10 | 0 | 12.50%18 | 12.50%9 | 0 | 12.50%9 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |